Saturday, May 10, 2025
CN
  • About
  • Advertise
  • Careers
  • Contact
Money Compass
  • Home
  • Financial News
  • Investment News
  • Other News
    • Bursa News
    • Government News
    • Listing Companies News
    • Oversea Financial & Investment News
  • Interviews
    • Features Interviews
    • Corporate Interviews
  • Financial & Investment Articles
  • PR Newswire
  • Login
No Result
View All Result
Money Compass
Home PR Newswire

GSK Leads Global Forum in Bangkok to Address Respiratory Health Challenges

by
December 17, 2024
in PR Newswire
0
GSK Leads Global Forum in Bangkok to Address Respiratory Health Challenges
0
SHARES
18
VIEWS
Share on FacebookShare on Twitter

GSK hosted the third annual RespiVerse Meeting on December 13 and 14 in Bangkok, Thailand. The event brought together renowned international speakers and healthcare professionals from 17 countries to address pressing global challenges in respiratory diseases, focusing on innovative solutions and collaborative strategies to advance respiratory health worldwide.

BANGKOK, Dec. 17, 2024 /PRNewswire/ — Dr. Gur Levy, Respiratory Medical Expert at GSK, said, “We have been pioneering efforts for decades to develop new therapeutic alternatives that set the standard for next-generation treatments and redefine the future of respiratory medicines for hundreds of millions of people with respiratory diseases.”

Related posts

Graid Technology to Showcase Breakthrough AI and HPC Storage Solutions with Leading Partners at AI EXPO KOREA 2025

Graid Technology to Showcase Breakthrough AI and HPC Storage Solutions with Leading Partners at AI EXPO KOREA 2025

May 10, 2025
Graid Technology to Showcase Breakthrough AI and HPC Storage Solutions with Leading Partners at AI EXPO KOREA 2025

Graid Technology to Showcase Breakthrough AI and HPC Storage Solutions with Leading Partners at AI EXPO KOREA 2025

May 10, 2025

By collaborating with top-level specialist physicians and highly qualified experts from around the world, GSK has developed a world-class program to achieve excellence in clinical practices and optimise new respiratory treatment outcomes for millions of patients.

“We research and develop a portfolio of vaccines, targeted biological products, and inhaled medicines at the forefront of the respiratory sector, aiming to improve outcomes and enhance the lives of people suffering from all types of asthma, COPD, and RSV. GSK is leveraging the latest scientific and technological advances to address the underlying dysfunction of these diseases and prevent their progression,” said Levy.

This year’s RespiVerse Meeting featured prominent international speakers and participants from regions including Southeast Asia, Latin America, Central America, and others. It integrated science, technology, and talent to identify the main clinical challenges in the respiratory area with an aim to develop scientific content that enhances the knowledge and professional practices of pulmonologists in Southeast Asia, the Middle East, Africa, and Latin America. The expert panel focused on four respiratory pathologies: moderate asthma, severe asthma, chronic obstructive pulmonary disease (COPD), and respiratory syncytial virus (RSV).

“Prevention is the cornerstone of public health, and the need is urgent when addressing respiratory diseases like respiratory syncytial virus (RSV), which can be more prevalent and dangerous than the flu. At GSK, we are dedicated to advancing vaccine innovation to protect vulnerable populations, particularly older adults, especially those with underlying medical conditions such as asthma, COPD, diabetes, and heart disease, from the significant health risks posed by RSV. By prioritizing prevention, we aim to ease the burden of RSV and promote healthier communities worldwide, especially in the context of an aging global society,” said Dr. Arnas Berzanskis, VP & Regional Medical Affairs Head – Vaccines at GSK.

As part of this event, a media session featured renowned experts in the field including: Dr. Le Khac Bao, Deputy Head of Lung Disease Department, Gia Dinh People’s Hospital; Dr. Fariz Nurwidya, Chairman and Associate Professor Division of Immunology and Interstitial Lung Disease, Department of Pulmonology and Respiratory Medicine Universitas Indonesia and Pulmonologist at Persahabatan Hospital dan Bunda General Hospital Jakarta; and Dr. Pailin Ratanawatkul, Assistant Professor in Pulmonary and Critical Care Medicine and Associate Director of the Center of Excellence at Srinagarind Hospital, Khon Kaen University. They discussed the causes and consequences of respiratory diseases affecting populations worldwide and challenges to be overcome.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/gsk-leads-global-forum-in-bangkok-to-address-respiratory-health-challenges-302333254.html

SOURCE GSK

​ 

Previous Post

Trinasolar establishes a partnership with Centro Universitário FACENS to empower Brazilian market on its advanced smart solar solutions

Next Post

HTX Ventures Identifies Five Rapidly-Growing Sectors in 2024, Expects Positive Crypto Regulations Driven by Trump Next Year

Next Post
HTX Ventures Identifies Five Rapidly-Growing Sectors in 2024, Expects Positive Crypto Regulations Driven by Trump Next Year

HTX Ventures Identifies Five Rapidly-Growing Sectors in 2024, Expects Positive Crypto Regulations Driven by Trump Next Year

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

BROWSE BY CATEGORIES

  • Blog
  • Bursa News
  • Corporate Interviews
  • Features Interviews
  • Financial & Investment Articles
  • Financial News
  • Government News
  • Investment News
  • Listing Companies News
  • Oversea Financial & Investment News
  • PR Newswire

BROWSE BY TOPICS

2018 League Balinese Culture Bali United Budget Travel business Champions League Chopper Bike Doctor Terawan industrial Istana Negara Malaysia Market Stories National Exam net zero emissions targets 2025 Renewable energy Visit Bali

Recent News

  • Graid Technology to Showcase Breakthrough AI and HPC Storage Solutions with Leading Partners at AI EXPO KOREA 2025
  • Graid Technology to Showcase Breakthrough AI and HPC Storage Solutions with Leading Partners at AI EXPO KOREA 2025
  • Education Cannot Wait Scales-Up Funding for Education in Somalia with US$17 Million Catalytic Grant

Category

  • Blog
  • Bursa News
  • Corporate Interviews
  • Features Interviews
  • Financial & Investment Articles
  • Financial News
  • Government News
  • Investment News
  • Listing Companies News
  • Oversea Financial & Investment News
  • PR Newswire
  • About
  • Advertise
  • Careers
  • Contact

Copyright © 2024 Money Compass Media (M) Sdn Bhd. All Rights Reserved

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Features Interviews
  • Government News
  • Financial News
  • Investment News
  • Listing Companies News
  • Corporate Interviews
  • Bursa News
  • Financial & Investment Articles
  • Oversea Financial & Investment News

Copyright © 2024 Money Compass Media (M) Sdn Bhd. All Rights Reserved